liquiritigenin has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Ni, Y; Ning, X; Zhang, H | 1 |
| Fang, H; Li, L; Liu, SX; Yang, ZQ; Yu, YH | 1 |
2 other study(ies) available for liquiritigenin and Cardiac Diseases
| Article | Year |
|---|---|
Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen; Cytokines; Heart Diseases; Inflammation; Interleukin-6; Mice; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2023 |
Liquiritigenin attenuates isoprenaline‑induced myocardial fibrosis in mice through the TGF‑β1/Smad2 and AKT/ERK signaling pathways.
Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Flavanones; Heart Diseases; Heart Function Tests; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1 | 2021 |